Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCG vaccine (Bio Farma)
- Development stage
- Unknown
- Lead developer
- Bio Farma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal
01
Overview
The BCG vaccine produced by PT Bio Farma is a live attenuated biological vaccine derived from the Bacillus Calmette-Guérin (BCG) strain of *Mycobacterium bovis*. It is primarily used for active immunization against tuberculosis (TB), targeting the prevention of disease caused by *Mycobacterium tuberculosis* infection. As a freeze-dried preparation, it has been a staple of Indonesia's basic immunization program since 1977, administered primarily to infants and children. PT Bio Farma, an Indonesian state-owned manufacturer, is one of the largest vaccine producers in Southeast Asia and supplies this vaccine globally under WHO pre-qualification status. Recent clinical research by the company includes Phase 2 bridging studies to evaluate the safety and tuberculin conversion of a multi-dose vial presentation compared to the traditional registered ampoule format.
- Brand names
- BCG Vaccine Vial (Bio Farma)BCG Vaccine Ampoule (Bio Far name)
- Other names
- Vaksin BCG Bio FarmaBCG vaccine-PT Bio Farma-tuberculosisBacillus Calmette-Guérin vaccine (Bio Farma)
Beyond the preview
Go deeper on BCG vaccine (Bio Farma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCG vaccine (Bio Farma).